Category Archives: Ulcerative Colitis

The U.S. Food and Drug Administration (FDA) recently required the manufacturers of arthritis medications Xeljanz (tofacitinib) and Xeljanz XR (extended-release) to add new warnings to their medications. These warnings will alert doctors and patients to an increased risk of serious heart-related events such as heart attack and stroke, cancer, blood clots, and death. Continue reading →

Ulcerative colitis (UC) is a type of inflammatory bowel disease (IBD). It is a chronic condition that causes inflammation and sores to form in the inner lining of the rectum and colon, which make up the large intestine Continue reading →

I vividly remember the day when everything in my life changed. Continue reading →

When Takeda teamed up with Finch Therapeutics on inflammatory bowel disease (IBD), it planned to pick up programs after theyd finished phase 2 trials. Now, the Japanese pharma is moving that timeline up, taking the lead on an ulcerative colitis program before it hits the clinic Continue reading →

Johnson & Johnsons Bold Stelara campaign found a new audience during the televised Olympics. Continue reading →

MONTREAL, Aug. 12, 2021 (GLOBE NEWSWIRE) -- People in Quebec living with Crohns disease or ulcerative colitis (the main forms of IBD) have had to be very patient along their health journey. In many cases, theyve tried several different treatment options, often enduring severe side effects and painful flareups, all in the pursuit of stabilizing their health. Continue reading →

The Ulcerative Colitis Market for the forecasting period of 2019-2028. The report is made out with a comprehensive analysis of the current market and pulled down the key factors that propel the growth of the Ulcerative Colitis Market in the forecasted period. This report also encompasses key market drivers and the hindering restraints of the Ulcerative Colitis Market Continue reading →

() () URL() Bridge Biotherapeutics said Friday that it recorded sales of 1.3 billion won ($11.3 million) and a net loss of 11.7 billion won based on consolidated financial statements in the first half of this year. The new drug developer added that it spent 9 billion won on research and development in the first six months. In an online investor relation (IR) conference, Bridge Bio said the company drastically beefed up its R&D workforce as its primary pipelines progressed, and new pipelines were added, leading to a 45 percent increase in ordinary R & R&D expense Continue reading →

Last Price $ Last Trade Change $ Change Percent % Open $ Prev Close $ High $ low $ 52 Week High $ 52 Week Low $ Market Cap PE Ratio Volume Exchange FNCH - Market Data & News Finch Therapeutics Group Inc (NASDAQ: FNCH) fell to close at $13.15 Friday after losing $0.85 (6.07%) on volume of 23,448 shares. The stock ranged from a high of $14.03 to a low of $13.13 while Finchs market cap now stands at $623,956,283 Continue reading →

A family have been torn apart after both a dad and a daughter died just ten days apart from each other. Dad-of-six David Andrew Morris tested positive for coronavirus on July 12, and was rushed into hospital a few days later. Continue reading →